Carlsmed Q3 2026 Results: Net Loss of $12.2M, Loss Widens
Carlsmed, Inc. reported revenue of $56.6 million for the nine months ended September 30, 2026, a significant increase from $35.3 million in the prior year period. Despite the revenue growth, the company recorded a net loss of $31.5 million for the first nine months of 2026 as operating expenses, particularly in sales, marketing, and general administration, increased substantially.
- Key figure
- Net loss $12.2M